Why Fast-paced Mover Brookdale (BKD) Is a Great Choice for Value Investors
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Brookdale (BKD) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Wall Street Analysts See a 25.3% Upside in Brookdale (BKD): Can the Stock Really Move This High?
The consensus price target hints at a 25.3% upside potential for Brookdale (BKD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Should Value Investors Buy Brookdale Senior Living (BKD) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Brookdale Senior Living (BKD) Stock Outpacing Its Medical Peers This Year?
Here is how Brookdale Senior Living (BKD) and Halozyme Therapeutics (HALO) have performed compared to their sector so far this year.
Despite Fast-paced Momentum, Brookdale (BKD) Is Still a Bargain Stock
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Brookdale (BKD) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Here's What Brookdale's Occupancy Growth Story Tells Us
BKD is likely to have witnessed 40 straight months of year-over-year increases in weighted average occupancy.
Brookdale Expands Real Estate Portfolio With Strategic Acquisitions
BKD expands its real estate footprint with the closure of two acquisitions.
Brookdale Incurs Loss in Q4 Due to Higher Costs, Shares Up 6%
BKD's Q4 results reflect escalating general and administrative costs, partly offset by improved occupancy rates. It projects 2025 adjusted EBITDA within $430-$445 million.
Brookdale (BKD) Is Attractively Priced Despite Fast-paced Momentum
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Brookdale (BKD) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Wall Street Analysts Believe Brookdale (BKD) Could Rally 35.41%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 35.4% in Brookdale (BKD). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Should Value Investors Buy Brookdale Senior Living (BKD) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Brookdale Senior Living Inc. (BKD) Q4 2024 Earnings Call Transcript
Brookdale Senior Living Inc. (NYSE:BKD ) Q4 2024 Earnings Conference Call February 19, 2025 9:00 AM ET Company Participants Jessica Hazel - Head of IR Lucinda Baier - President & CEO Dawn Kussow - EVP & CFO Conference Call Participants Tao Qiu - Macquarie Brian Tanquilut - Jefferies Josh Raskin - Nephron Research Ben Hendrix - RBC Joanna Gajuk - Bank of America Operator Good morning. My name is Audra and I will be your conference operator today.
